icon-    folder.gif   Conference Reports for NATAP  
 
  15th CROI
Conference on Retroviruses and Opportunistic Infections Boston, MA
Feb 3-6, 2008
Back grey_arrow_rt.gif
 
 
 
Tropism Change from Screening to Baseline Matters: Virological Correlates Associated with Treatment Failure at Week 48 in the Phase 3 Study of Maraviroc in Treatment-Naive Patients
 
 
  Reported by Jules Levin
CROI 2008, Boston
 
Jayvant Heera1, Mike Saag2, Prudence Ive3, Jeannette Whitcomb4, Marilyn Lewis5, Lynn McFadyen5, James Goodrich1, Howard Mayer1, Elna van der Ryst5, and Mike Westby5
 
1Pfizer Global Research and Development, New London, CT, USA
2University of Alabama at Birmingham, Birmingham, AL, USA
3University of the Witwatersrand, Johannesburg, South Africa
4Monogram Biosciences Inc., South San Francisco, CA, USA
5Pfizer Global Research and Development, Sandwich, UK

Merit-1.gif

week-2.gif

obj-3.gif

trop-4.gif

Select-5.gif

incomp-6.gif

mean-7.gif

DM-8.gif